WARF TECHNOLOGIES

A UW researcher has developed a method of supplementing the diet of infants to prevent the development of type 1 diabetes in children. This researcher also developed a synthetic insulin analog that prevents type 1 diabetes. He identified a few naturally occurring dietary molecules that can be given to infants from 4-6 months old at high risk of developing type 1 diabetes. These molecules modify insulin to prevent the immune system from recognizing the protein as foreign in these children at a time when the immune system is developing rapidly. This dietary supplementation should prevent the destruction of the pancreatic cells in these kids. The synthetic insulin peptide achieves the same results.

• Michael MacDonald

• Therapeutics & Vaccines : Metabolic disorders